Early manifestations of nephropathy in alloxan-treated rats

Renal Failure

Volumn 20, Issue 4, 1998, Pages 551-564

  García, Verónica M C ^a   Girardi, Guillermina ^a   Ochoa, J Elena ^b   Torres, Adriana M ^a   Elías, M Mónica ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Alloxan; Fibronectin; Glycosylated proteins; Mieloperoxidase; Rat renal clearance

Indexed keywords

4 AMINOHIPPURIC ACID; ALLOXAN; FIBRONECTIN; GLYCOSYLATED PROTEIN; INULIN; MYELOPEROXIDASE;

4 AMINOHIPPURIC ACID CLEARANCE; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIURESIS; GLOMERULUS FILTRATION RATE; GLUCOSURIA; IMMUNOHISTOCHEMISTRY; INULIN CLEARANCE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN URINE LEVEL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031853676     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045147     Document Type: Article

References (39)

1. Nathan D: Long term complications of diabetes mellitus. N Engl J Med 328: 1676-1685, 1993.
2. Zatz R, Meyer T, Rennke H and Brenner B: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U.S.A. 82: 5963-5967, 1985.
3. Adler S. Structure-function relationships associates with extracellular matrix alterations in diabetic glomerulopathy: J Am Soc Nephrol 5: 1165-1172, 1994.
4. Johnson RJ, García R, Pritze P and Alpers C: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136: 369-374, 1990.
5. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnic E, Delaney V, Friedman EA, Cerami A and Vlassara H: Advanced glycosylation end products in patients with diabetic nephrophathy. N Engl J Med 325: 836-842, 1991.
6. Sakamoto K, Kikkawa R, Haneda M and Shigeta Y: Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia 38: 536-542, 1995.
7. Tollins J, Shultz P, Raij L, Brown D and Mauer M: Abnormal renal hemodynamic response to reduce renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265: F886-F895, 1993.
8. Baykal-Erkiliç A, Erkiliç M and Ozben T: The effects of streptozotocin-induced diabetes on renal plasma flow. Exp Clin Endocrinol 103: 367-372, 1995.
9. Torres AM, Rodriguez JV, Ochoa JE and Elías MM: Rat kidney function related to tissue glutathione levels. Biochem Pharmacol 35: 3355-3361, 1986.
10. Girardi G, Torres AM and Elías MM: The implication of renal glutathione levels in mercuric chloride nephrotoxicity. Toxicology 58: 187-195, 1989.
11. Mantle M and Allen A: A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain. Biochemical Society Transaction 6: 607-609, 1978.
12. Komatzu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, Guth PH and Kaplowitz N: Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 262: G669-G676, 1992.
13. Andrews PC and Krinsky NI: Human myeloperoxidase and hemi-myeloperoxidase. Methods Enzymol 132: 369-378, 1986.
14. Pick-Kober KH, Munker D and Gressmer AM: Fibronectin is synthetized as an acute phase reactant in rat hepatocytes. J Clin Chem Biochem 24: 521-528, 1986.
15. Waugh WH and Beall PT: Simplified meassurement of PAH and other arylamines in plasma and urine. Kidney Int 5: 429-432, 1974.
16. Roe HH: A photometric method for determination of inulin in plasma and urine. J Biol Chem 178: 839-844, 1949.
17. Dunn JS, Kirkpatrick J, McLetchie NJB and Telfer SV: Necrosis of the islets of Langerhans produced experimentally. J Path Bacteriol 45: 245-257, 1943.
18. Malaisse W: Alloxan toxicity to the pancreatic β cell. Biochem Pharmacol 31: 3527-3534, 1982.
19. Park B-H, Rho H-W, Park J-W, Cho Ch-G, Kim J-S, Chung H-T and Kin H-R: Protective mechanism of glucose against alloxan-induced pancreatic β-cell damage. Biochem Biophys Res Commun 210: 1-6, 1995.
20. Sandler S and Swenne I: Streptozotocin, but not Alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro. Diabetologia 25: 444-447, 1983.
21. Rodrigues B, Grassby P, Battell M, Lee S and Mc Neill J: Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction. Can J Physiol Pharmacol 72: 447-455, 1994.
22. Tooke J: Microvascular function in human diabetes. Diabetes 44: 721-726, 1995.
23. Hostetter T, Troy J and Brenner B: Glomerular hemodynamic in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981.
24. Evan A, Mong S, Gattone V, Connors B, Aronoff G and Luft F: The effect of streptozotocin and streptozotocin-induced diabetes on the kidney. Renal Physiol, Basel 7: 78-89, 1984.
25. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y and Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41: 1520-1527, 1992.
26. Nakamura T, Fukui I, Ebihara I, Osada S, Tomino Y and Koide H: Abnormal gene expression of matrix metalloproteinase and their inhibitor in glomeruli from diabetic rats. Renal Physiol Biochem 17: 316-325, 1994.
27. Phan-Thanh L, Robert L, Derouette J and Labat-Robert J: Increased biosynthesis and processing of fibronectin in fibroblasts from diabetic mice. Proc Natl Acad Sci U.S.A. 84: 1911-1915, 1987.
28. Spadella CT, Mercadante EMS, Schellmi SA, Machado JLM, Oliveira WK and Bacchi CE: Effect of pancreas transplantation on the prevention of nephropathy in alloxan-induced diabetic rats. Braz J Med Biol Res 29: 1019-1024, 1996.
29. Grond J, Weening J and Elema J: Glomerular sclerosis in nephrotic rats. Lab Invest 51: 277-285, 1984.
30. Goode NP, Shires M, Crellin DM. Aparicio SR and Davison AM: Alterations of glomerular basement membrane charge structure in diabetic nephropathy. Diabetologia 38: 1455-1465, 1995.
31. Wheeler DC and Chana RS: Interactions between Lipoproteins, Glomerular Cells and Matrix. Miner Electrolyte Metab 19: 149-164, 1993
32. Lan HY, Nikolic-Paterson DJ, Mu W and Atkins RC: Local Macrophage Proliferation in Progressive Renal Injury. Koide H, Ichikawa I (eds): Progression of chronic renal diseases. Contrib Nephrol. Basel, Karger 118: 100-108, 1996.
33. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC and Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92: 471-478, 1993.
34. Kakkar R, Mantha SV, Radhi J, Prasad K and Kalra J: Antioxidant defense system in diabetic kidney: A time course study. Life Sci 60: 667-679, 1997.
35. Vlassara H: Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49: 1795-1804, 1996.
36. Collins T: Endothelial Nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 68: 499-508, 1993.
37. Vlassara H, Bucala R and Striker L: Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151, 1994.
38. Vlassara H, Brownlee M, Manogue K, Dinarello C and Passagian A: Cachectin/TNF and IL-I induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548, 1988.
39. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D and Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor, role in vascular disease of diabetes and aging. Proc Natl Acad Sci U.S.A. 87: 9010-9014, 1990.